SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All beta proteins (24004)
(-)
Fold: Immunoglobulin-like beta-sandwich (7299)
(-)
Superfamily: Immunoglobulin (5995)
(-)
Family: C1 set domains (antibody constant domain-like) (3013)
(-)
Protein domain: automated matches (652)
(-)
Human (Homo sapiens) [TaxId: 9606] (334)
1TZGL:107-213; M:107-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
1U6AL:108-213CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
1ZA6A:114-220; C:114-220; E:114-220; G:114-220THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
1ZLSL:108-210FAB 2G12 + MAN4
1ZLUK:108-212; L:108-212FAB 2G12 + MAN5
1ZLVK:108-212; L:108-212FAB 2G12 + MAN7
1ZLWK:108-212; L:108-210FAB 2G12 + MAN8
2AGJL:108-215CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
2AJ3A:108-213; C:108-213; E:108-213CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18
2BC4A:97-200; B:94-193; C:97-206; D:94-199CRYSTAL STRUCTURE OF HLA-DM
2BNUA:116-204STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
2CDGA:116-193STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
2CMRL:107-207CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
2D4DA:THE CRYSTAL STRUCTURE OF HUMAN BETA2-MICROGLOBULIN, L39W W60F W95F MUTANT
2EYRA:118-205; B:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYSA:118-205; B:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2EYTA:118-205; B:120-247; C:118-205; D:120-247A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2FJFA:108-211; C:108-211; E:108-211; G:108-211; J:108-211; L:108-211; M:108-211; O:108-211; Q:108-211; S:108-211; U:108-211; W:108-211STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB
2FJGA:108-211; L:108-211STRUCTURE OF THE G6 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FJHA:107-211; L:107-214STRUCTURE OF THE B20-4 FAB, A PHAGE DERIVED FAB FRAGMENT, IN COMPLEX WITH VEGF
2FSEA:82-181; C:82-180CRYSTALLOGRAPHIC STRUCTURE OF A RHEUMATOID ARTHRITIS MHC SUSCEPTIBILITY ALLELE, HLA-DR1 (DRB1*0101), COMPLEXED WITH THE IMMUNODOMINANT DETERMINANT OF HUMAN TYPE II COLLAGEN
2H9GA:108-211; L:108-211CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5)
2HFFA:107-213; L:107-210CRYSTAL STRUCTURE OF CB2 FAB
2HFGL:107-212CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
2IALA:110-198; B:113-240; C:110-198; D:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAMC:110-198; D:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2IAND:110-198; E:113-240; I:110-198; J:113-240; N:110-198; O:113-240; S:110-198; T:113-240STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED TCR
2J6EA:236-339; A:340-445; B:238-339; B:340-446; M:109-211CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
2JB5L:113-214FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-1
2JB6A:113-214; L:113-214FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN, CRYSTAL FORM-2
2NW2A:118-206CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
2NYYC:112-216CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2OLDA:113-217; B:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(2)21 CRYSTAL FORM
2OMBA:113-217; B:113-217; C:113-217; D:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P3(1)21 CRYSTAL FORM
2OMNA:113-217; B:113-217BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER, P4(3)2(1)2 CRYSTAL FORM
2PYFA:116-205; B:114-241CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
2QQKL:108-211NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQLL:107-214NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
2QQNL:108-214NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB
2R56L:108-211; M:108-211CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
2VLMD:113-201THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2VXQL:108-213CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2VXSL:109-210; M:109-212; N:109-210; O:109-212STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT, FULLY HUMAN NEUTRALISING ANTIBODY
2VXVL:108-213CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
2WAHA:238-339; A:340-444; B:237-339; B:340-445CRYSTAL STRUCTURE OF AN IGG1 FC GLYCOFORM (MAN9GLCNAC2)
2WBJB:93-188; C:114-200; F:93-190; G:114-202TCR COMPLEX
2WUBL:108-214; Q:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP
2WUCL:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON-INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
2X89D:; E:; F:; G:STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS
2XA8L:112-218CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2XKUA:PRION-LIKE CONVERSION DURING AMYLOID FORMATION AT ATOMIC RESOLUTION
2XNAA:112-200CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
2XPGB:CRYSTAL STRUCTURE OF A MHC CLASS I-PEPTIDE COMPLEX
2XQBL:108-209CRYSTAL STRUCTURE OF ANTI-IL-15 ANTIBODY IN COMPLEX WITH HUMAN IL-15
2XWTB:108-213CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
2XZAL:110-216CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2XZCL:110-216CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
2YK1L:108-205STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE
2YKLL:108-208STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE
3AGVA:241-339; A:340-443; B:237-339; B:340-444CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX
3BDYL:108-213DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3BE1L:108-212DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
3BN9C:108-210; E:108-211CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
3BQUA:108-211CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX
3BZFB:; D:THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E
3C08L:107-211CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB/EMD72000 (FAB72000)
3C2SA:236-339; A:340-445STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS
3C5JB:93-190CRYSTAL STRUCTURE OF HLA DR52C
3D85A:108-213CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
3DGGA:111-217; C:111-215CRYSTAL STRUCTURE OF FABOX108
3DIFA:108-213; C:108-214CRYSTAL STRUCTURE OF FABOX117
3DX9A:126-215; B:130-257; C:126-215; D:130-257CRYSTAL STRUCTURE OF THE DM1 TCR AT 2.75A
3EO9L:108-213CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB
3EOAA:108-214; L:108-214CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN, FORM I
3EYOA:109-213; C:109-214CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3EYQC:109-212CRYSTAL STRUCTURE OF MJ5 FAB, A GERMLINE ANTIBODY VARIANT OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3F12A:110-212; C:110-214GERMLINE V-GENES SCULPT THE BINDING SITE OF A FAMILY OF ANTIBODIES NEUTRALIZING HUMAN CYTOMEGALOVIRUS
3FJTA:236-339; A:340-444; B:236-339; B:340-444CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE
3FZUD:108-213; L:108-213IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3G6AA:109-210; L:109-210CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY CNTO607
3G6JE:107-214; G:107-214C3B IN COMPLEX WITH A C3B SPECIFIC FAB
3GBML:108-213; M:112-211CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
3GIZL:108-211CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CD20 ANTIBODY OFATUMUMAB
3GJEA:111-212; L:111-212RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
3GKWL:108-207CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
3GRWL:108-214FGFR3 IN COMPLEX WITH A FAB
3GSNA:112-200; B:117-244; H:182-274CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
3GSOA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV PEPTIDE
3GSQA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5S PEPTIDE VARIANT
3GSRA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5V PEPTIDE VARIANT
3GSUA:182-275CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5T PEPTIDE VARIANT
3GSVA:182-275CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-M5Q PEPTIDE VARIANT
3GSWA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8A PEPTIDE VARIANT
3GSXA:182-274CRYSTAL STRUCTURE OF THE BINARY COMPLEX BETWEEN HLA-A2 AND HCMV NLV-T8V PEPTIDE VARIANT
3H0TA:112-216HEPCIDIN-FAB COMPLEX
3H42L:113-214CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
3H9YA:336-438; A:439-544; B:335-438; B:439-544; E:336-438; E:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3H9ZA:336-438; A:439-544; B:336-438; B:439-544; C:336-438; C:439-544; D:336-438; D:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3HA0A:336-438; A:439-544; B:336-438; B:439-544; C:336-438; C:439-544; D:336-438; D:439-544; E:336-438; E:439-544; F:336-438; F:439-544CRYSTAL STRUCTURE OF THE IGE-FC3-4 DOMAINS
3HC0B:108-213; L:108-212BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
3HC3L:108-213BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HC4L:108-213BHA10 IGG1 FAB QUADRUPLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
3HI1A:108-214; L:108-214STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING-SITE ANTIBODY F105
3HI5L:107-211CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57
3HI6L:107-211; Y:107-210CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
3HMWL:107-214CRYSTAL STRUCTURE OF USTEKINUMAB FAB
3HMXL:107-214CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
3HUJE:118-206; F:119-247; G:118-206; H:119-247CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
3IDXL:108-213CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13, SPACE GROUP C222
3INUL:108-211; N:108-211CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY.
3JWDL:108-214; O:108-213STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3K2UL:108-214CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
3KR3L:109-214CRYSTAL STRUCTURE OF IGF-II ANTIBODY COMPLEX
3KYMA:108-213; C:108-213; E:108-213; G:108-213; I:108-213; K:108-212; M:108-208; O:108-213CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB
3L5XL:108-214CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB
3L7FA:108-213; D:108-213; L:108-213STRUCTURE OF IL-13 ANTIBODY H2L6, A HUMANIZED VARIANT OF C836
3LMJL:113-215STRUCTURE OF HUMAN ANTI HIV 21C FAB
3LRSB:108-209; D:108-209; F:108-209; L:108-209STRUCTURE OF PG16, AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3LZFL:108-211CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
3M1BA:177-267; C:177-267; E:177-267; G:177-267CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR
3M8OL:113-219HUMAN IGA1 FAB FRAGMENT
3MFFA:122-210; B:116-243; C:122-210; D:116-2431F1E8HU TCR
3MLRL:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
3MLSL:112-213; M:112-213; N:112-213; O:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV-1 GP120 V3 MIMOTOPE
3MLTA:112-213; D:112-213; G:112-213; L:112-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3MLUL:113-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
3MLVL:113-213; M:113-213CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
3MLWL:108-209; M:108-209CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3MLXL:109-209; M:109-209CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
3MLYL:108-211; M:108-211CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
3MLZL:108-211CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE
3MUGA:108-212; C:108-212; E:108-212; G:108-212; I:108-212; K:108-213CRYSTAL STRUCTURE OF HUMAN FAB PG16, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3MUHL:108-212CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
3MXWL:108-212CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
3N9GL:112-220CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI-WEST NILE VIRUS MAB CR4354
3NA9L:108-214CRYSTAL STRUCTURE OF FAB15
3NAAL:108-214CRYSTAL STRUCTURE OF FAB15 MUT5
3NABL:108-214CRYSTAL STRUCTURE OF FAB15 MUT6
3NACL:108-214CRYSTAL STRUCTURE OF FAB15 MUT7
3NCJL:108-214CRYSTAL STRUCTURE OF FAB15 MUT8
3NFPB:107-212; L:107-212CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
3NFSL:107-212CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB
3NPSC:108-212CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3NZHL:108-214CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
3O4LD:112-201GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
3O6FC:111-196; G:111-196CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
3OAYK:108-213; L:108-213A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OAZK:108-213; L:108-213A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OB0K:108-213; L:108-212A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
3OF6A:120-245; B:120-247; C:120-247HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3P0VL:108-212; M:108-212ANTI-EGFR/HER3 FAB DL11 ALONE
3P0YL:108-213ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
3PGFL:108-214CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
3PL6B:95-191; C:114-192STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
3PWPE:118-246THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3Q6FA:108-211; C:108-211; E:108-211; G:108-211; I:108-211; K:108-211CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
3QDGD:111-199; E:118-245THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3QDJD:111-199; E:118-245THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QDMD:110-196; E:116-243THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
3QEGL:108-212CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB, AN ADCC AND NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEHB:107-210; D:107-210; F:107-210; H:107-210CRYSTAL STRUCTURE OF HUMAN N12-I15, AN ADCC AND NON-NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY
3QEQD:110-195THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
3QEUA:111-201; B:118-241; D:111-201; E:118-245THE CRYSTAL STRUCTURE OF TCR DMF5
3QFJE:118-246THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
3QH3A:112-194; B:117-245; C:112-194; D:117-245THE CRYSTAL STRUCTURE OF TCR A6
3QHFL:108-213CRYSTAL STRUCTURE OF FAB DEL2D1, A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
3QHZL:108-215; M:108-212CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
3QIBC:112-201CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK
3QNXA:113-219ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QNYA:113-219; C:113-219MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT, SHARING SAME FV AS IGG
3QO1A:113-219MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
3QOS  [entry was replaced by entry 5I1D without any SCOP domain information]
3QOT  [entry was replaced by entry 5I18 without any SCOP domain information]
3QPQC:108-215; E:108-215; I:108-215; L:108-215CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3QPXL:107-213CRYSTAL STRUCTURE OF FAB C2507
3QQ9C:112-217; L:112-217CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3QRGL:112-217CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
3R1GL:108-214STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE-BINDING ANTIBODY
3REVA:118-205; B:116-242CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3RPIB:97-202; L:97-202CRYSTAL STRUCTURE OF FAB FROM 3BNC60, HIGHLY POTENT ANTI-HIV ANTIBODY
3S7GA:236-339; A:340-443; B:236-339; B:340-442; C:237-339; C:340-444; D:238-339; D:340-444AGLYCOSYLATED HUMAN IGG1 FC FRAGMENT
3SDXE:115-203; G:115-203CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
3SDYL:108-214CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ
3SE8L:108-213CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120
3SE9L:108-214CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG04 IN COMPLEX WITH HIV-1 GP120
3SKJL:108-214; M:108-214STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
3SKNA:125-214; B:127-255; C:125-214; D:127-255; E:125-214; F:127-255; G:125-214; H:127-255CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3SO3B:108-213STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON-CANONICAL MECHANISM OF INHIBITION.
3T2NL:109-209; M:109-210HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3TCLB:108-213; L:108-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04
3THML:112-214CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01
3TJEL:112-213CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB E09
3TNMB:108-208; L:108-208CRYSTAL STRUCTURE OF A32 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
3TNNB:109-210; D:109-210; F:109-210; L:109-210CRYSTAL STRUCTURE OF N5-I5 FAB, AN ADCC MEDIATING AND NON-NEUTRALIZING CD4I ANTI-HIV- 1 ANTIBODY.
3TO4C:118-207; D:122-247STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
3TV3L:108-211CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT128 IN COMPLEX WITH MAN9
3TWCL:108-214CRYSTAL STRUCTURE OF BROAD AND POTENT HIV-1 NEUTRALIZING ANTIBODY PGT127 IN COMPLEX WITH MAN9
3TZVA:115-200; G:115-203CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D-LYSOPHOSPHATIDYLCHOLINE
3U2SB:108-208; L:108-208CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
3U30B:108-211; E:108-211CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
3U46B:108-213; L:108-213CH04H/CH02L P212121
3U4BL:108-213CH04H/CH02L FAB P4
3U4EB:108-209; L:108-210CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN CAP45
3UTPD:113-200; E:118-246; K:113-202; L:118-2461E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
3V7MA:236-339; A:340-444CRYSTAL STRUCTURE OF MONOCLONAL HUMAN ANTI-RHESUS D FC IGG1 T125(YB2/0) IN THE PRESENCE OF ZN2+
3VWJC:118-206TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
3VWKC:118-204; D:119-246TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE COMPLEX
3VXQA:114-204; D:114-204H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
3VXTA:112-200; C:112-200T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3W9DB:108-212; D:108-213STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
3W9EB:108-211STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB COMPLEX WITH HSV-2 GD
3WD5L:107-213CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
3ZL4L:111-216ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA - LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY
4AENB:93-190HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION
4AL8L:108-213STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
4AM0B:108-212; D:108-212; F:108-212; L:108-212STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
4B7IA:237-339; A:340-444; B:238-339; B:340-444CRYSTAL STRUCTURE OF HUMAN IGG FC BEARING HYBRID-TYPE GLYCANS
4D9LL:109-209; M:109-210; N:109-210; O:109-210FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
4D9QD:108-213; L:108-213INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4D9RD:108-213; L:108-214INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4DKFL:107-212; M:107-208CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
4DN3L:109-214CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
4DQOL:108-210CRYSTAL STRUCTURE OF PG16 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
4DTGL:112-219HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
4DZBA:111-199; B:118-245MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR, VALPHA7.2JALPHA33-VBETA2
4E41D:111-199; E:111-238; I:111-198; J:111-238STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4E42A:111-198; B:111-238; C:111-198; D:111-238STRUCTURAL BASIS FOR THE RECOGNITION OF MUTANT SELF BY A TUMOR-SPECIFIC, MHC CLASS II-RESTRICTED T CELL RECEPTOR G4
4EDWL:108-214NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
4EN3A:114-201CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
4EOWL:112-212CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
4ERSL:107-214A MOLECULAR BASIS FOR NEGATIVE REGULATION OF THE GLUCAGON RECEPTOR
4EVNB:113-215; D:113-215; F:113-215; H:113-215; J:113-215; L:113-215; N:113-215; P:113-215CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE-REVERTED LIGHT CHAIN)
4F57L:109-209FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L1 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4F58L:109-209; M:109-209; N:109-209; O:109-209FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4FNLL:107-213; M:107-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4FP8L:107-213; M:107-213; N:107-213; O:107-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ, HA1 SUBUNIT
4FQ2L:109-212CRYSTAL STRUCTURE OF 10-1074 FAB
4FQHB:108-209; L:108-209CRYSTAL STRUCTURE OF FAB CR9114
4FQIL:108-208CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ
4FQJL:108-211INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX
4FQLL:108-214INFLUENZA B HA ANTIBODY (FAB) CR8033
4FQQA:109-210; C:109-209; E:109-209; L:109-212CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
4FQXB:93-190; C:97-200; D:94-193CRYSTAL STRUCTURE OF HLA-DM BOUND TO HLA-DR1
4FZ8L:108-211CRYSTAL STRUCTURE OF C11 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4FZEL:108-210CRYSTAL STRUCTURE OF N26_I1 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
4G3YL:108-214CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
4G7VL:108-211CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.5 A)
4G7YL:108-211CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E, 2.8 A)
4G8EA:128-217; B:135-262CRYSTAL STRUCTURE OF CLONE18 TCR
4G8FA:129-205; B:128-256CRYSTAL STRUCTURE OF CLONE42 TCR
4GKZA:116-201; B:115-242HA1.7, A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
4GRLA:82-180; B:95-191; C:114-192CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
4GRMA:118-194; B:118-246; C:118-193; D:118-245THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
4GSDL:109-211H5.3 FAB STRUCTURE
4GT7A:334-438; A:439-545; B:333-438; B:439-545; C:332-438; C:439-545; D:333-438; D:439-545AN ENGINEERED DISULFIDE BOND REVERSIBLY TRAPS THE IGE-FC3-4 IN A CLOSED, NON-RECEPTOR BINDING CONFORMATION
4GW4B:97-199; L:97-198CRYSTAL STRUCTURE OF 3BNC60 FAB WITH P61A MUTATION
4GXVL:108-209; M:108-209CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
4H25B:93-190; E:93-190TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY
4H26B:93-190; E:93-190TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY
4H8WL:109-209CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.
4HCRL:112-218; N:112-218CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
4HF5L:108-208CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFUL:107-212CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4HFWA:107-211; L:107-212ANTI ROTAVIRUS ANTIBODY
4HH9A:108-214; C:108-214ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
4HJGA:108-214MEDITOPE-ENABLED TRASTUZUMAB
4HK0B:110-210; D:110-210UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HK3N:110-210I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE
4HKXB:110-211INFLUENZA HEMAGGLUTININ IN COMPLEX WITH CH67 FAB
4HKZA:108-213TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
4HQQL:108-208CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
4HWEL:105-210CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
4I2XA:108-214; C:108-214CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
4I3RL:107-214CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
4I3SL:108-214CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
4I77L:108-214LEBRIKIZUMAB FAB BOUND TO IL-13
4IIQA:111-201; B:117-244CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
4IOIA:108-214MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
4IRJC:116-204STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
4J12A:236-339; A:340-444MONOMERIC FC
4J4PD:131-233; L:131-233THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
4J6RL:108-214CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120
4JAMB:108-209; L:108-209CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
4JANB:106-207; L:106-207CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4JB9L:103-209CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE
4JDVB:104-209; L:104-209CRYSTAL STRUCTURE OF GERM-LINE PRECURSOR OF NIH45-46 FAB
4JFHD:111-200; E:117-244HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
4JFXA:108-214; L:108-214STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
4JFYA:108-211; L:108-213APO STRUCTURE OF PHOSPHOTYROSINE (PYAB) SCAFFOLD
4JFZL:108-214STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG0L:108-214STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE
4JG1L:108-214STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE
4JHAL:108-211CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
4JM2B:107-214; C:110-212CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4JM4L:108-214CRYSTAL STRUCTURE OF PGT 135 FAB
4JPIB:110-214; L:110-213CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPKL:110-214CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4JPVL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120
4JPWL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 12A21 IN COMPLEX WITH HIV-1 STRAIN 93TH057 GP120 MUTANT
4JY5L:109-209CRYSTAL STRUCTURE OF HUMAN FAB PGT122, A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4K71B:177-268; E:177-268CRYSTAL STRUCTURE OF A HIGH AFFINITY HUMAN SERUM ALBUMIN VARIANT BOUND TO THE NEONATAL FC RECEPTOR
4K7PX:108-214GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
4KMTL:108-214CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
4KQ3L:107-211CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
4KVNL:107-212CRYSTAL STRUCTURE OF FAB 39.29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/PERTH/16/2009 (H3N2)
4KY1L:108-213HUMANIZED HP1/2 FAB
4L4TD:111-200; G:111-199STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
4L4VD:111-200; G:111-198STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
4L8SA:111-200CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
4LCWD:111-200; G:111-198THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
4LFHG:126-238CRYSTAL STRUCTURE OF 9C2 TCR
4LHUG:126-236CRYSTAL STRUCTURE OF 9C2 TCR BOUND TO CD1D
4LKCA:109-214AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
4LMQI:108-214; L:108-214DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
4LSPL:108-212CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057
4LSQL:108-213CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-CH31 IN COMPLEX WITH HIV-1 CLADE A/E GP120 93TH057 WITH LOOP D AND LOOP V5 FROM CLADE A STRAIN 3415_V1_C1
4LSUL:108-211CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC-PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4M6ML:113-216CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
4M6OL:108-214CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
4MAYA:82-180; B:95-191; C:114-192CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
4MNGA:184-278; C:184-278STRUCTURE OF THE DP10.7 TCR WITH CD1D-SULFATIDE
4MWFB:108-213; L:108-213STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
4NDMA:119-246; B:122-212STRUCTURE OF THE AB18.1 TCR
4NM4L:108-213; M:108-213CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
4NRZB:108-212; L:108-213CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
4NZRL:108-214CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB
4NZTL:108-212CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4NZUL:108-211CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB' FROM A MULTIPLE MYELOMA PATIENT
4OAWC:108-214FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
4OCSL:108-209CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD1L:108-208CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.03, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4OD3L:108-209CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07, A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4PS4L:107-213CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB